Phase II Trial of Neoadjuvant Chemotherapy With Carboplatin and NAB-Paclitaxel in Patients With Locally Advanced and Inflammatory Triple Negative Breast Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT01525966

Title field or adapter rule

{'original_value': 'Phase II Trial of Neoadjuvant Chemotherapy With Carboplatin and NAB-Paclitaxel in Patients With Locally Advanced and Inflammatory Triple Negative Breast Cancer', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:30.223574+00:00

Published At

2023-03-10T00:00:00+00:00

Record Updated At

2026-10-29

Results Posted At

2023-03-10

Source Retrieved At

2026-10-31T22:18:22.973355+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Inflammatory Breast Cancer", "Stage IIA Breast Cancer", "Stage IIIA Breast Cancer", "Stage IIIB Breast Cancer", "Stage IIIC Breast Cancer", "Triple-negative Breast Cancer", "Stage IIB Breast Cancer", "Estrogen Receptor Negative", "Progesterone Receptor Negative", "HER2/Neu Negative"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-10-29", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT01525966"

protocolSection.identificationModule.officialTitle

"Phase II Trial of Neoadjuvant Chemotherapy With Carboplatin and NAB-Paclitaxel in Patients With Locally Advanced and Inflammatory Triple Negative Breast Cancer"

protocolSection.statusModule.overallStatus

"ACTIVE_NOT_RECRUITING"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct

{"date": "2023-03-10", "type": "ACTUAL"}

Study condition terms

• Inflammatory Breast Cancer (protocolSection.conditionsModule.conditions)
• Stage IIA Breast Cancer (protocolSection.conditionsModule.conditions)
• Stage IIIA Breast Cancer (protocolSection.conditionsModule.conditions)
• Stage IIIB Breast Cancer (protocolSection.conditionsModule.conditions)
• Stage IIIC Breast Cancer (protocolSection.conditionsModule.conditions)
• Triple-negative Breast Cancer (protocolSection.conditionsModule.conditions)
• Stage IIB Breast Cancer (protocolSection.conditionsModule.conditions)
• Estrogen Receptor Negative (protocolSection.conditionsModule.conditions)
• Progesterone Receptor Negative (protocolSection.conditionsModule.conditions)
• HER2/Neu Negative (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['Treatment (carboplatin and nab-paclitaxel)'], 'description': 'Given IV', 'name': 'carboplatin', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Treatment (carboplatin and nab-paclitaxel)'], 'description': 'Given IV', 'name': 'paclitaxel albumin-stabilized nanoparticle formulation', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Treatment (carboplatin and nab-paclitaxel)'], 'description': 'Correlative studies', 'name': 'laboratory biomarker analysis', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

• carboplatin (protocolSection.armsInterventionsModule.interventions[].name)
• paclitaxel albumin-stabilized nanoparticle formulation (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.